In the ever-evolving landscape of European biopharma investment, the last year has seen significant milestones, with GSK investing €1 million in a biotech campus and AstraZeneca committing £1 billion to R&D and Corporate HQ. To thrive in this dynamic environment, the Lab Asset and Facility Management in Pharma Europe returns for its second year. This expert-led summit focuses on sharing insights to enhance operational excellence in laboratories across Europe. The event takes place from March 19 to 21, 2024, building on the success of 2023 and helping stakeholders navigate the challenges of the biopharma industry.
Over the past year, European biopharma investment has witnessed significant milestones, including GSK's €1 million investment in a biotech campus and AstraZeneca's £1 billion commitment to R&D and Corporate HQ. With the need to navigate a diverse and decentralized market to expand and advance pipelines, the Lab Asset and Facility Management in Pharma Europe returns for its second year. This expert-led summit focuses on sharing insights to expedite operational excellence in laboratories across Europe. Join senior leaders from AstraZeneca, Novartis, and Abcam to discuss asset optimization, workspace efficiency, sustainability, digitization, contract relationships, and GxP enhancement. The event is scheduled from March 19 to 21, 2024, building on the success of 2023
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our